We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis Infection (PREDICT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01162265
Recruitment Status : Completed
First Posted : July 14, 2010
Last Update Posted : October 1, 2020
Sponsor:
Collaborators:
Imperial College London
Queen Mary University of London
University College, London
Brunel University
University of Birmingham
Information provided by (Responsible Party):
Public Health England

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 30, 2015
Actual Study Completion Date : June 30, 2016
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):